EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Unveiling the Revolutionary Potential: Exploring Blockchain Technology in Pharma
The pharmaceutical industry is renowned for its stringent regulations complex supply chains and crucial emphasis on data integrity In recent years the emergence of blockchain technology has sparked considerable interest
Cold Chain Logistics for Pharmaceuticals: A Complete Guide to Compliance, Technology, and Best Practices
In the pharmaceutical industry preserving the integrity of temperaturesensitive products is crucial Cold chain logistics for pharmaceuticals play a vital role in ensuring that vaccines biologics and other temperaturesensitive medicines reach patients safely and effectively This complete guide explores pharmaceutical cold chain management focusing on compliance innovative technology and industry be...
Cell and Gene Therapy's Trillion-Dollar Reckoning Is Here
Cell and gene therapies can cure diseases once thought untreatable Yet a string of commercial collapses now suggests that curing the patient and sustaining the business are two very different challenges and the industry is confronting the gap at last
Quality by Design Is a Mindset, Not a Milestone
Every medicine is a promise about consistency The tablet dispensed in Milan next spring must behave exactly like the one tested in a trial four years earlier and like the ten million made between them
Acquisitions of Small-Medium Pharma Companies in EU
In EU the middleclass in Pharma is disappearing companies with revenues by M with a small factory and operations limited to some few countries
Digital Health and Wearables: Integration with Pharmaceuticals for Improved Patient Outcomes
Digital health is the application of telecommunication technologies that allow people to control and maintain their health through their smartphone applications sensors and the cloud Mobile devices are while not the only ones an important factor in this digital health environment wearable fitness smart watches and health monitoring devices occupy this niche These wearables can track things as si...
-
Techno Trends
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC
-
Projects
Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion
Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
-
2
Cell and Gene Therapy's Trillion-Dollar Reckoning Is Here
Lakshmi
Cell and gene therapies are transforming medicine, but commercial sustainability remains their greatest challenge. Despite scientific breakthroughs and a rapidly expanding pipeline, many developers fa...
-
3
Quality by Design Is a Mindset, Not a Milestone
Lakshmi
Quality by Design has been embedded in European regulatory expectation for nearly two decades, yet it is still widely treated as a dossier section rather than an operating philosophy. This article exa...
-
4
Acquisitions of Small-Medium Pharma Companies in EU
Angel Calvo Yague
In EU the “middle-class” in Pharma is disappearing; companies with revenues by 50 – 100 M€, with a small factory and operations limited to some few countries, belonging to a fam...
-
5
Digital Health and Wearables: Integration with Pharmaceuticals for Improved Patient Outcomes
Harry Callum
Integrating a form of digital health and wearable technology is becoming increasingly beneficial in healthcare delivery since it provides real time monitoring, treatment, and results. Interlinked with...
press releases Read more...
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Amneal Pharmaceuticals Inc Amneal or the Company NASDAQ AMRX today announced that the US Food and Drug Administration FDA has approved its lanreotide injection mg mL in a sterile
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA
Acelot Announces Initiation of Dosing in Phase Ia Clinical Trial of ACE-2223, a First-in-Class Oral Small Molecule Targeting Aggregated TDP-43 in Amyotrophic Lateral Sclerosis (ALS)
Acelot a biotechnology company developing small molecule therapies for challenging targets in diseases with high unmet need today announced the initiation of the Phase Ia clinical trial of ACE
Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution
Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWS Read more...
BioCytics and Eremid collaborate on single-cell sequencing study for cancer cell therapy
BioCytics Inc has engaged Eremid Genomic Services to sequence an autologous immune cell fraction being developed for its immunebased cancer cell therapy programme
MAbxience and Sandoz collaborate to advance global access to emicizumab biosimilar
MAbxience majorityowned by Fresenius SE Co KGaA with partial ownership from Insud Pharma has entered into a licensing development manufacturing and commercialisation agreement with Sandoz for an emicizumab
Orbis Medicines enters multi-target drug discovery partnership with Novo Nordisk
Orbis Medicines has entered a strategic collaboration and licence agreement with Novo Nordisk to discover and develop nextgeneration oral macrocycle medicines for cardiometabolic diseases
Everest Clinical Research expands global biometrics capabilities with Firma DS acquisition
Everest Clinical Research has acquired the Biometrics and Data Services business unit of Firma Clinical Research expanding its global biometrics expertise and clinical data science capabilities
Novo Nordisk and Anthropic collaborate to advance AI-led drug discovery
Novo Nordisk and Anthropic have announced a collaboration to accelerate drug discovery and development using artificial intelligence AI while also expanding AIsupported software development at Novo
Twist Bioscience joins Lilly TuneLab to support antibody drug discover
Twist Bioscience has entered into an agreement with Lilly TuneLab an artificial intelligence and machine learning AIML drug discovery platform developed by Eli Lilly and Company





